Business Wire

REPLY: The Jury for the Second Edition of the Reply AI Film Festival Is Announced, Which Will Celebrate the Best AI-generated Short Films

8.5.2025 11:23:00 CEST | Business Wire | Press Release

Share

Reply, an international group specialised in the development of new business models enabled by Artificial Intelligence and long committed to the exploration of emerging technologies and supporting the growth of new talent, announces the jury for the second edition of the Reply AI Film Festival. The international competition open to creatives, filmmakers, and videomakers who wish to experiment with the production of short films using AI tools and explore the continuous evolution of the collaboration of human creativity and technology and the power that this combination brings to storytelling.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250508567831/en/

The jury for the second edition of the Reply AI Film Festival is announced, which will be held during the 82nd Venice International Film Festival (Photo: REPLY)

The jury will be chaired by Gabriele Muccino, an Italian director and screenwriter known for films such as The Pursuit of Happyness, and Seven Pounds. Joining him on the panel for the second edition of the Reply AI Film Festival are returning members Rob Minkoff, co-director of The Lion King and creator of numerous films including Stuart Little, The Haunted Mansion, and Mr. Peabody & Sherman; Caleb & Shelby Ward, co-founders of Curious Refuge, the first online community dedicated to filmmakers using Artificial Intelligence; and Denise Negri, journalist for SkyTg24 and Sky Arte, and correspondent for major international film events such as the Academy Awards, Cannes, and Venice Film Festivals. New to the jury this year are Dave Clark, founder and Chief Creative Officer of Promise, a production company focused on films, series, and innovative formats created in collaboration with some of the world’s most talented GenAI artists and storytellers worldwide, and Charlie Fink, columnist for Forbes US and expert in Augmented Reality, Virtual Reality, and AI. The jury also includes Filippo Rizzante, Chief Technology Officer at Reply; Caroline Ingeborn, Chief Operating Officer at Luma AI, a platform for creating highly realistic 3D images and videos; Paolo Moroni, Head of Lexus Italy; and Guillem Martinez Roura, AI & Robotics Lead at ITU AI for Good, the United Nations initiative focused on harnessing AI for the benefit of society.

The theme chosen for the 2025 edition is "Generation of Emotions" — an invitation to explore how Artificial Intelligence can evoke authentic and engaging emotions through cinematic language. The jury will evaluate submissions — due by June 1st, 2025 via the platform aiff.reply.com — based on creativity, production quality, and the use of AI in the various stages of development, from script to post-production.

Gabriele Muccino commented:“The Reply AI Film Festival is a pioneering event showcasing technology and art's exciting intersection. AI is not a replacement for human creativity, but a catalyst for innovation. It will enable filmmakers to explore new styles, genres, and narratives that were previously unimaginable. As President of the Reply AIFF Jury, I'm honoured to be part of this journey, discovering new talents and celebrating the bold experiments that will shape the future of cinema. The AI revolution is just beginning, and I'm thrilled to be at the forefront of this creative explosion.”

“The role of AI in the future of the film industry won’t be about replacing filmmakers—it’ll be about expanding what’s creatively possible. It will be a creative collaborator, helping filmmakers visualise ideas faster, experiment more freely, and bring ambitious stories to life with fewer limitations. From pre-production to post, AI will streamline workflows and democratise access to powerful tools, opening doors for more diverse voices and bold storytelling. But filmmaking will always be human at the core because AI can’t feel joy, loss, or love. It hasn’t lived the stories we’re here to tell. Used with intention, AI won’t diminish creativity but elevate it,” said Dave Clark founder and Chief Creative Officer of Promise.

“We are delighted to launch the second edition of the AI Film Festival because we believe in the importance of creating spaces and opportunities to experiment with emerging technologies,” said Filippo Rizzante, CTO of Reply. “The success of the first edition, with over 1,000 short films submitted from 59 countries, underlinesthe globalinterest — not only among the younger generations — in initiatives that challenge both technical and creative skills.”

In addition to selecting the most outstanding original short films, the jury will also award two special prizes that are new to this edition: the Lexus Visionary Award, recognising the most visionary and innovative production that successfully integrates technology, design and forward-thinking, in line with the values that have always guided Lexus' approach to creativity; and the AI for Good Award, promoted in partnership with the International Telecommunication Union (ITU), which recognises the best short film that highlights the United Nations Sustainable Development Goals (SDGs).

Paolo Moroni, Head of Lexus Italy, commented: “It is an honour to be part of the jury for this festival, which invites us to explore how Artificial Intelligence can accelerate the creation of authentic and engaging emotions through the language of cinema, combining innovation, creativity and vision. Much like Lexus - with whom it shares values such as innovation, creativity and forward thinking - this competition celebrates the evolution of film and technology's ability to support the generation of deep emotions, constantly pushing the boundaries of imagination.”

“I'm thrilled to join the Reply AI Film Festival as a juror and to present the 'AI for Good Award'. This festival is a unique opportunity to showcase the creative potential of generative AI technologies in storytelling. I'm looking forward to seeing how filmmakers use AI to tell compelling stories, highlighting the importance of sustainable development. AI can be a powerful tool for driving positive change, and I'm excited to see how the festival will inspire new ideas and innovations," said Guillem Martinez Roura, AI & Robotics Lead at ITU "AI for Good"

The creatives behind the shortlisted works will be invited to a premiere event, organised by Reply and Mastercard, taking place in September in Venice where the three overall winners will be officially announced.

Reply

Reply [EXM, STAR: REY, ISIN: IT0005282865] specialises in the design and implementation of solutions based on new communication channels and digital media. Reply is a network of highly specialised companies supporting key European industrial groups operating in the telecom and media, industry and services, banking, insurance and public administration sectors in the definition and development of business models enabled for the new paradigms of big data, cloud computing, digital media and the Internet of Things. Reply services include: Consulting, System Integration and Digital Services. www.reply.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20250508567831/en/

Contacts

Reply
Fabio Zappelli
f.zappelli@reply.com
Tel. +390117711594

Irene Caia
i.caia@reply.com
Tel. +39 02 535761

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye